ID
22652
Description
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Keywords
Versions (1)
- 6/8/17 6/8/17 -
Copyright Holder
Genentech, Inc.
Uploaded on
June 8, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
PHYSICAL EXAM (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
PHYSICAL EXAM (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
Description
PHYSICAL EXAM (SCREENING)
Similar models
PHYSICAL EXAM (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
C2986440 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])